Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel A Fuertes

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Chemical Reviews|March 13, 2003
Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistanceMiguel A Fuertes, Carlos Alonso, José M Pérez
Journal of Molecular Evolution|March 1, 2019
Conserved Critical Evolutionary Gene Structures in OrthologsMiguel A Fuertes, José R Rodrigo, Carlos Alonso
Chemical Reviews|June 15, 2006
Molecular mechanisms for the B-Z transition in the example of poly[d(G-C) x d(G-C)] polymers. A critical reviewMiguel A Fuertes, Victoria Cepeda, Carlos Alonso, et al.
Journal of Molecular Evolution|December 7, 2010
Introns form compositional clusters in parallel with the compositional clusters of the coding sequences to which they pertainMiguel A Fuertes, José M Pérez, Emile Zuckerkandl, et al.
Molecular Pharmacology|October 24, 2003
Pharmacological modulation of Poly(ADP-ribose) polymerase-mediated cell death: exploitation in cancer chemotherapyPaul A Nguewa, Miguel A Fuertes, Carlos Alonso, et al.
Progress in Biophysics and Molecular Biology|November 25, 2004
Poly(ADP-ribose) polymerases: homology, structural domains and functions. Novel therapeutical applicationsPaul A Nguewa, Miguel A Fuertes, Basilio Valladares, et al.
Trends in Parasitology|July 13, 2004
Programmed cell death in trypanosomatids: a way to maximize their biological fitness?Paul A Nguewa, Miguel A Fuertes, Basilio Valladares, et al.
Retina (Philadelphia, Pa.)|November 25, 2010
Diagnostic and therapeutic challengesFrancisco J Ascaso, Beatriz Jimenez, Miguel A Fuertes, et al.
Current Medicinal Chemistry|February 22, 2008
Anticancer compounds as leishmanicidal drugs: challenges in chemotherapy and future perspectivesMiguel A Fuertes, Paul A Nguewa, Josefina Castilla, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 3, 2007
Biochemical mechanisms of cisplatin cytotoxicityVictoria Cepeda, Miguel A Fuertes, Josefina Castilla, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Chemical Reviews|March 13, 2003
Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistanceMiguel A Fuertes, Carlos Alonso, José M Pérez
Journal of Molecular Evolution|March 1, 2019
Conserved Critical Evolutionary Gene Structures in OrthologsMiguel A Fuertes, José R Rodrigo, Carlos Alonso
Chemical Reviews|June 15, 2006
Molecular mechanisms for the B-Z transition in the example of poly[d(G-C) x d(G-C)] polymers. A critical reviewMiguel A Fuertes, Victoria Cepeda, Carlos Alonso, et al.
Journal of Molecular Evolution|December 7, 2010
Introns form compositional clusters in parallel with the compositional clusters of the coding sequences to which they pertainMiguel A Fuertes, José M Pérez, Emile Zuckerkandl, et al.
Molecular Pharmacology|October 24, 2003
Pharmacological modulation of Poly(ADP-ribose) polymerase-mediated cell death: exploitation in cancer chemotherapyPaul A Nguewa, Miguel A Fuertes, Carlos Alonso, et al.
Progress in Biophysics and Molecular Biology|November 25, 2004
Poly(ADP-ribose) polymerases: homology, structural domains and functions. Novel therapeutical applicationsPaul A Nguewa, Miguel A Fuertes, Basilio Valladares, et al.
Trends in Parasitology|July 13, 2004
Programmed cell death in trypanosomatids: a way to maximize their biological fitness?Paul A Nguewa, Miguel A Fuertes, Basilio Valladares, et al.
Retina (Philadelphia, Pa.)|November 25, 2010
Diagnostic and therapeutic challengesFrancisco J Ascaso, Beatriz Jimenez, Miguel A Fuertes, et al.
Current Medicinal Chemistry|February 22, 2008
Anticancer compounds as leishmanicidal drugs: challenges in chemotherapy and future perspectivesMiguel A Fuertes, Paul A Nguewa, Josefina Castilla, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 3, 2007
Biochemical mechanisms of cisplatin cytotoxicityVictoria Cepeda, Miguel A Fuertes, Josefina Castilla, et al.
Pageof 3